» Articles » PMID: 31311130

Male-Specific Long Noncoding RNA Inhibits Non-Small Cell Lung Cancer Proliferation and Metastasis Via TBX4

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Jul 18
PMID 31311130
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Gender affects cancer susceptibility. Currently, there are only a few studies on Y chromosome-linked long noncoding RNAs (lncRNAs), and the potential association between lncRNAs and cancers in males has not been fully elucidated. Here, we examined the expression of testis-specific transcript Y-linked 15 () in 37 males with non-small cell lung cancer (NSCLC), and performed circular chromosome conformation capture with next-generation sequencing to determine the genomic interaction regions of the gene. Our results showed that the expression levels of were lower in NSCLC tissues. Lower expression levels were associated with Tumor-Node-Metastasis (TNM) stage. A knockdown promoted malignant transformation of NSCLC cells. Based on the bioinformatics analysis of circular chromosome conformation capture data, we found that T-box transcription factor 4 (TBX4) may be a potential target gene of . The RNA immunoprecipitation and chromatin immunoprecipitation results showed that may interact with DNA (cytosine-5)-methyltransferase 3A (DNMT3A), and the knockdown increased the binding of DNMT3A to the TBX4 promoter. We concluded that low expression correlates with worse prognosis among patients with NSCLC. promotes TBX4 expression via DNMT3A-mediated regulation. The identification of lncRNAs encoded by male-specific genes may help to identify potential targets for NSCLC therapy.

Citing Articles

Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review).

Dai C, Qianjiang H, Fu R, Yang H, Shi A, Luo H Int J Oncol. 2025; 66(4).

PMID: 40017127 PMC: 11900940. DOI: 10.3892/ijo.2025.5735.


The regulatory role and therapeutic potential of long non-coding RNA in non-small cell lung cancer.

Xia S, Lu X, Wang W, Pan X, Cui J, Wang S J Cancer. 2025; 16(4):1137-1148.

PMID: 39895777 PMC: 11786035. DOI: 10.7150/jca.103182.


Research on Correlations of lncRNA ST7-AS1 with Progression and Therapeutic Targets of Esophageal Cancer.

Lin X, Sun S, Zhang J, Cai Y, Cheng Q Turk J Gastroenterol. 2024; 36(2):82-88.

PMID: 39696960 PMC: 11843310. DOI: 10.5152/tjg.2024.24260.


Cancer fusion transcripts with human non-coding RNAs.

Mohammad T, Zolotovskaia M, Suntsova M, Buzdin A Front Oncol. 2024; 14:1415801.

PMID: 38919532 PMC: 11196610. DOI: 10.3389/fonc.2024.1415801.


Identification of m6A/m5C-related lncRNA signature for prediction of prognosis and immunotherapy efficacy in esophageal squamous cell carcinoma.

Wang J, Ren H, Xu C, Yu B, Cai Y, Wang J Sci Rep. 2024; 14(1):8238.

PMID: 38589454 PMC: 11001862. DOI: 10.1038/s41598-024-58743-y.


References
1.
Egeblad M, Werb Z . New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2(3):161-74. DOI: 10.1038/nrc745. View

2.
Naiche L, Papaioannou V . Loss of Tbx4 blocks hindlimb development and affects vascularization and fusion of the allantois. Development. 2003; 130(12):2681-93. DOI: 10.1242/dev.00504. View

3.
Skaletsky H, Kuroda-Kawaguchi T, Minx P, Cordum H, Hillier L, Brown L . The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature. 2003; 423(6942):825-37. DOI: 10.1038/nature01722. View

4.
Dekker J . A closer look at long-range chromosomal interactions. Trends Biochem Sci. 2003; 28(6):277-80. DOI: 10.1016/S0968-0004(03)00089-6. View

5.
Lundgren R, Mandahl N, Heim S, Limon J, HENRIKSON H, Mitelman F . Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer. 1992; 4(1):16-24. DOI: 10.1002/gcc.2870040103. View